| Mathieu, Nicolas |
CYTOVEDO, NCT04064697: Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy |
|
|
| Terminated | 3 | 6 | Europe | Valganciclovir, antiviral therapy | Centre Hospitalier Universitaire de Saint Etienne, Ministry of Health, France | Ulcerative Colitis, Unspecified | 11/23 | 02/24 | | |
| Recruiting | 3 | 612 | Europe, Canada, Japan, US, RoW | ABX464, Obefazimod, Placebo | Abivax S.A. | Ulcerative Colitis | 03/25 | 04/25 | | |
| Recruiting | 3 | 1050 | Europe, Canada, Japan, US, RoW | ABX464, Obefazimod, Placebo | Abivax S.A. | Ulcerative Colitis | 01/26 | 01/30 | | |
Rhoneswitch, NCT04422171: A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar |
|
|
| Recruiting | N/A | 400 | Europe | | University Hospital, Grenoble | IBD Patients, Originator Treatment, Biosimilar, Switch Back | 06/21 | 01/23 | | |
PEREM, NCT04990258: A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC |
|
|
| Active, not recruiting | N/A | 444 | Europe | Subcutaneous infliximab CT-P13 Remsima®SC | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, Celltrion | Inflammatory Bowel Diseases | 06/24 | 09/24 | | |
SOFA, NCT06186999: Social and Demographic Determinants of Fatigue in Patients With Inflammatory Bowel Disease in Remission |
|
|
| Completed | N/A | 208 | Europe | | University Hospital, Grenoble | Inflammatory Bowel Diseases, Remission, Fatigue | 06/24 | 06/24 | | |
DOPER, NCT05158517: VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study |
|
|
| Active, not recruiting | N/A | 349 | Europe | Subcutaneous vedolizumab | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, Takeda | Inflammatory Bowel Diseases | 03/24 | 03/25 | | |
| Not yet recruiting | N/A | 216 | Europe | Sleep activity, Questionnaires | Hospices Civils de Lyon | Disease Bowel, Crohn Disease, Ulcerative Colitis | 01/28 | 01/28 | | |
Deeper, NCT04973423: STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP |
|
|
| Recruiting | N/A | 180 | Europe | MRI | University Hospital, Clermont-Ferrand | Crohn Disease, Calprotectin, MRI | 03/27 | 08/27 | | |
| Chateau, Thomas |
DOPER, NCT05158517: VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study |
|
|
| Active, not recruiting | N/A | 349 | Europe | Subcutaneous vedolizumab | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, Takeda | Inflammatory Bowel Diseases | 03/24 | 03/25 | | |
